These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 29343259)

  • 1. Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus.
    Gimenes R; Gimenes C; Rosa CM; Xavier NP; Campos DHS; Fernandes AAH; Cezar MDM; Guirado GN; Pagan LU; Chaer ID; Fernandes DC; Laurindo FR; Cicogna AC; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2018 Jan; 17(1):15. PubMed ID: 29343259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.
    Rosa CM; Gimenes R; Campos DH; Guirado GN; Gimenes C; Fernandes AA; Cicogna AC; Queiroz RM; Falcão-Pires I; Miranda-Silva D; Rodrigues P; Laurindo FR; Fernandes DC; Correa CR; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2016 Sep; 15(1):126. PubMed ID: 27585437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rutin administration attenuates myocardial dysfunction in diabetic rats.
    Guimaraes JF; Muzio BP; Rosa CM; Nascimento AF; Sugizaki MM; Fernandes AA; Cicogna AC; Padovani CR; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2015 Jul; 14():90. PubMed ID: 26185015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine restores autophagy and cardiac dysfunction in rats with streptozotocin-induced diabetes mellitus.
    Oh JE; Jun JH; Hwang HJ; Shin EJ; Oh YJ; Choi YS
    Acta Diabetol; 2019 Jan; 56(1):105-114. PubMed ID: 30206697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
    Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
    Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase inhibitor apocynin prevents atrial remodeling in alloxan-induced diabetic rabbits.
    Qiu J; Zhao J; Li J; Liang X; Yang Y; Zhang Z; Zhang X; Fu H; Korantzopoulos P; Liu T; Li G
    Int J Cardiol; 2016 Oct; 221():812-9. PubMed ID: 27434350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction.
    Hayashi T; Juliet PA; Kano-Hayashi H; Tsunekawa T; Dingqunfang D; Sumi D; Matsui-Hirai H; Fukatsu A; Iguchi A
    Diabetes Obes Metab; 2005 Jul; 7(4):334-43. PubMed ID: 15955119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature.
    Shida T; Nozawa T; Sobajima M; Ihori H; Matsuki A; Inoue H
    Heart Vessels; 2014 Jul; 29(4):532-41. PubMed ID: 23979266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apocynin attenuates left ventricular remodeling in diabetic rabbits.
    Qiu J; Zhao J; Li J; Liang X; Yang Y; Zhang Z; Zhang X; Fu H; Korantzopoulos P; Tse G; Liu T; Li G
    Oncotarget; 2017 Jun; 8(24):38482-38490. PubMed ID: 28388570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats.
    Rosa CM; Xavier NP; Henrique Campos D; Fernandes AA; Cezar MD; Martinez PF; Cicogna AC; Gimenes C; Gimenes R; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2013 Oct; 12():152. PubMed ID: 24134628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes.
    Liu Y; Lei S; Gao X; Mao X; Wang T; Wong GT; Vanhoutte PM; Irwin MG; Xia Z
    Clin Sci (Lond); 2012 Feb; 122(4):161-73. PubMed ID: 21892921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
    Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
    Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH
    Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.
    Chen Y; Du J; Zhao YT; Zhang L; Lv G; Zhuang S; Qin G; Zhao TC
    Cardiovasc Diabetol; 2015 Aug; 14():99. PubMed ID: 26245924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
    Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy.
    Mano Y; Anzai T; Kaneko H; Nagatomo Y; Nagai T; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
    Circ J; 2011; 75(7):1717-27. PubMed ID: 21519150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy.
    Dong B; Yu QT; Dai HY; Gao YY; Zhou ZL; Zhang L; Jiang H; Gao F; Li SY; Zhang YH; Bian HJ; Liu CX; Wang N; Xu H; Pan CM; Song HD; Zhang C; Zhang Y
    J Am Coll Cardiol; 2012 Feb; 59(8):739-47. PubMed ID: 22340266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction.
    Roe ND; Thomas DP; Ren J
    Diabetes Obes Metab; 2011 May; 13(5):465-73. PubMed ID: 21272185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NADPH oxidase mediates mitochondrial oxidative stress and atrial remodeling in diabetic rabbits.
    Zhou L; Liu Y; Wang Z; Liu D; Xie B; Zhang Y; Yuan M; Tse G; Li G; Xu G; Liu T
    Life Sci; 2021 May; 272():119240. PubMed ID: 33600862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.